Matches in Wikidata for { <http://www.wikidata.org/entity/Q61921315> ?p ?o ?g. }
Showing items 1 to 63 of
63
with 100 items per page.
- Q61921315 description "assaig clínic" @default.
- Q61921315 description "clinical trial" @default.
- Q61921315 description "clinical trial" @default.
- Q61921315 description "clinical trial" @default.
- Q61921315 description "clinical trial" @default.
- Q61921315 description "ensaio clínico" @default.
- Q61921315 description "ensayo clínico" @default.
- Q61921315 description "ensayu clínicu" @default.
- Q61921315 description "essai clinique" @default.
- Q61921315 description "klinisch onderzoek" @default.
- Q61921315 description "клінічне випробування" @default.
- Q61921315 description "կլինիկական փորձարկում" @default.
- Q61921315 description "临床试验" @default.
- Q61921315 name "Maraviroc in Rheumatoid Arthritis" @default.
- Q61921315 type Item @default.
- Q61921315 label "Maraviroc in Rheumatoid Arthritis" @default.
- Q61921315 prefLabel "Maraviroc in Rheumatoid Arthritis" @default.
- Q61921315 P1050 Q61921315-51213EBF-085B-41D1-9C63-03B12BE98532 @default.
- Q61921315 P1132 Q61921315-AB1277B0-20B0-4E04-BD4D-BC0FBD21254D @default.
- Q61921315 P1476 Q61921315-4799FE6F-1AFF-428C-85FF-C8A9474B115D @default.
- Q61921315 P17 Q61921315-090F1AFF-DFF3-41CA-A593-991E50B0AFE7 @default.
- Q61921315 P17 Q61921315-46290C25-3B4E-486B-9FD6-231EA26019BB @default.
- Q61921315 P17 Q61921315-48D1ED9D-8F27-4928-9ECD-4ACB67B9A9F7 @default.
- Q61921315 P17 Q61921315-54D3E8C6-5509-4F70-B6B1-D0CFD4520F7A @default.
- Q61921315 P17 Q61921315-55CF18DE-4786-424B-9E1F-56939C1953EE @default.
- Q61921315 P17 Q61921315-6EDF696B-EC6D-435A-B6A6-2D637BFDCDA8 @default.
- Q61921315 P17 Q61921315-6F5B6577-6F8F-40E8-95DC-7FB1BC7C3345 @default.
- Q61921315 P17 Q61921315-B1F97C9F-4DA9-446C-9AFB-ABD9220824D3 @default.
- Q61921315 P17 Q61921315-B9BB0207-5F5C-4CE2-80E8-5855E41A1CC9 @default.
- Q61921315 P2899 Q61921315-1A812D16-04E1-4B4D-9923-A28330C4AF62 @default.
- Q61921315 P3098 Q61921315-0ED2C4CA-95B6-4C56-924D-DACBD8B8B1A0 @default.
- Q61921315 P31 Q61921315-17E8B806-D1B4-4861-9D50-EA62D8631719 @default.
- Q61921315 P4844 Q61921315-DAB5C924-D033-4879-964A-4D7081513A09 @default.
- Q61921315 P580 Q61921315-94DEC933-E9AC-4B80-A3FE-3E734AC2A7A0 @default.
- Q61921315 P582 Q61921315-7D3E5472-AB6B-45C2-B98C-97F3BC662D2F @default.
- Q61921315 P6099 Q61921315-DF4C9A3B-D31A-4147-9B86-43724C1143AA @default.
- Q61921315 P6153 Q61921315-B96EFE78-7EF8-45DE-AE98-FD0790D3AB5F @default.
- Q61921315 P8005 Q61921315-1C230311-B28C-47DC-8F05-56A0677291E6 @default.
- Q61921315 P8363 Q61921315-CA2834E1-41A7-4C51-AA15-0719A3CDF258 @default.
- Q61921315 P859 Q61921315-BB0A35C8-070C-4230-8C0E-A8E357CF2FCE @default.
- Q61921315 P1050 Q170990 @default.
- Q61921315 P1132 "+128" @default.
- Q61921315 P1476 "A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Efficacy of Maraviroc in the Treatment of Rheumatoid Arthritis in Subjects Receiving Methotrexate" @default.
- Q61921315 P17 Q183 @default.
- Q61921315 P17 Q212 @default.
- Q61921315 P17 Q29 @default.
- Q61921315 P17 Q30 @default.
- Q61921315 P17 Q38 @default.
- Q61921315 P17 Q408 @default.
- Q61921315 P17 Q45 @default.
- Q61921315 P17 Q668 @default.
- Q61921315 P17 Q96 @default.
- Q61921315 P2899 "+18" @default.
- Q61921315 P3098 "NCT00427934" @default.
- Q61921315 P31 Q30612 @default.
- Q61921315 P4844 Q421369 @default.
- Q61921315 P580 "2007-02-01T00:00:00Z" @default.
- Q61921315 P582 "2008-10-01T00:00:00Z" @default.
- Q61921315 P6099 Q42824440 @default.
- Q61921315 P6153 Q206921 @default.
- Q61921315 P8005 Q76649944 @default.
- Q61921315 P8363 Q78089383 @default.
- Q61921315 P859 Q206921 @default.